Eli Lilly and Company & Marvell Technology
4 shared events · Importance 4 · Last updated Jun 30, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.
Marvell Technology: Marvell Technology>>> saw a significant jump in its stock price as it was set to join the S&P 500>>>, signaling increased investor confidence and market recognition.
May 20, 2026 · 72 articles
Business
Eli Lilly and Company: Eli Lilly's stock jumped after a committee of the European Medicines Agency recommended one of its medicines for approval, boosting its market performance.
Marvell Technology: Fell up to 10.7% in a single session; volatile swings.
Apr 20, 2026 · 344 articles
International
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
Marvell Technology: Marvell Technology>>> rose after UBS>>> raised its target price, reflecting investor confidence in its performance.
May 27, 2026 · 101 articles
International
Eli Lilly and Company: Eli Lilly and Company>>> advanced after CVS Health>>> announced it would restore coverage for its weight-loss injection, Zepbound, and add its new obesity pill Foundayo.
Marvell Technology: Marvell Technology>>> rose after UBS>>> raised its target price, reflecting investor confidence in its performance.
May 18, 2026 · 309 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Eli Lilly and Company and Marvell Technology interact across events, view sentiment trends, and discover connected entities.
Open Dashboard